Literature DB >> 1574997

Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomography.

J Tedroff1, S M Aquilonius, P Hartvig, H Lundqvist, P Bjurling, B Långström.   

Abstract

The intracerebral kinetics of [11C]-labelled L-3,4-dihydroxyphenylalanine, L-DOPA, was investigated in rhesus monkeys by positron emission tomography (PET). Through the labelling of the L-DOPA molecule in different positions and observation of a series of pharmacological challenges it was possible to establish that the kinetic conversion of the radiotracer in the striatum represents the process of decarboxylation to [11C]-labelled dopamine. The rate constant for this process can be estimated using a two-compartment model. The use of [11C]-L-DOPA and PET will thus provide a possibility for in vivo studies of blood-brain barrier transport of the amino acid as well as for the estimation of the ability for brain tissue to decarboxylate the tracer by the action of aromatic L-amino acid decarboxylase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574997     DOI: 10.1111/j.1600-0404.1992.tb04021.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

1.  Brain kinetics of 11 C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the rhesus monkey. A study using positron emission tomography.

Authors:  P Hartvig; K J Lindner; J Tedroff; Y Andersson; P Bjurling; B Långström
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.

Authors:  H Tsukada; N Harada; S Nishiyama; H Ohba; T Kakiuchi
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.

Authors:  P Hartvig; R Torstenson; J Tedroff; Y Watanabe; K J Fasth; P Bjurling; B Långström
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Pyridoxine effect on synthesis rate of serotonin in the monkey brain measured with positron emission tomography.

Authors:  P Hartvig; K J Lindner; P Bjurling; B Laengstrom; J Tedroff
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 5.  A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.

Authors:  George E Jaskiw; Anand P Popli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

6.  Influence of O-methylated metabolite penetrating the blood-brain barrier to estimation of dopamine synthesis capacity in human L-[β-(11)C]DOPA PET.

Authors:  Keisuke Matsubara; Yoko Ikoma; Maki Okada; Masanobu Ibaraki; Tetsuya Suhara; Toshibumi Kinoshita; Hiroshi Ito
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

7.  Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography.

Authors:  P Hartvig; K J Lindner; J Tedroff; P Bjurling; K Hörnfelt; B Långström
Journal:  J Neural Transm Gen Sect       Date:  1992

8.  Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography.

Authors:  P Hartvig; H Agren; L Reibring; J Tedroff; P Bjurling; T Kihlberg; B Långström
Journal:  J Neural Transm Gen Sect       Date:  1991

9.  Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on in vivo L-[beta-11C]dopa turnover in the rat striatum with infusion of L-tyrosine.

Authors:  H Tsukada; K J Lindner; P Hartvig; Y Tani; P Bjurling; T Kihlberg; G Westerberg; Y Watanabe; B Långström
Journal:  J Neural Transm Gen Sect       Date:  1994

10.  Positron emission tomographic measure of brain dopamine dependence to nicotine as a model of drugs of abuse.

Authors:  Edward F Domino; Hideo Tsukada; Norihiro Harada
Journal:  Psychopharmacology (Berl)       Date:  2009-01-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.